Our data also indicate fructose-bisphosphate aldolase A (ALDOA) is a candidate marker of late-stage ccRCC, which has been observed in other ccRCC studies, but not specifically as a marker of late-stage ccRCC. This evidence concerns the gene ALDOA and nonpapillary renal cell carcinoma.